The panel’s recommendations could shape the future of popular peptides, but some doctors say the review process itself deserves closer scrutiny.

Safety concerns take a backseat

The panel’s recommendations could shape the future of popular peptides, but some doctors say the review process itself deserves closer scrutiny.